The use of medications like ACE inhibitors or angiotensin receptor blockers (ARBs) to manage microalbuminuria could help reduce both renal and cardiovascular risks, aligning with evidence that controlling renal dysfunction improves cardiovascular outcomes in diabetes [16,21]. The gene discussed is ACE; the disease is diabetes mellitus.